Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Depreciation and Depletion (2019 - 2025)

Historic Depreciation and Depletion for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $100000.0.

  • Puma Biotechnology's Depreciation and Depletion changed 0.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $400000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $400000.0 for FY2024, which is 0.0% changed from last year.
  • Puma Biotechnology's Depreciation and Depletion amounted to $100000.0 in Q3 2025, which was down 0.0% from $100000.0 recorded in Q2 2025.
  • Puma Biotechnology's Depreciation and Depletion's 5-year high stood at $200000.0 during Q1 2021, with a 5-year trough of $100000.0 in Q4 2021.
  • For the 5-year period, Puma Biotechnology's Depreciation and Depletion averaged around $126315.8, with its median value being $100000.0 (2021).
  • The largest annual percentage gain for Puma Biotechnology's Depreciation and Depletion in the last 5 years was 0.0% (2021), contrasted with its biggest fall of 5000.0% (2021).
  • Puma Biotechnology's Depreciation and Depletion (Quarter) stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Its Depreciation and Depletion stands at $100000.0 for Q3 2025, versus $100000.0 for Q2 2025 and $100000.0 for Q1 2025.